Jon Hamrick, partner at Curatio Advisors, discusses how product attributes, company size and stakeholder alignment shape pharma commercialization strategy.
DOL's final rule requires PBMs to disclose rebates and formulary incentives to large self-insured plans for plan years ...
In this week’s Pharma Pulse, GoodRx expands an employer offering built on manufacturer pricing for GLP-1 obesity drugs, a ...
Why outdated paper prescribing information is creating unnecessary cost, complexity and friction across a modern ...
Anthony “TJ” Rizzo, chief commercial officer, Cold Chain Technologies, shares what steps the industry should take to prepare the next generation of cold chain operators.
EVERSANA is folding Estima Scientific's AI-powered HEOR tools into its market access offerings as its CEO says evidence ...
Walgreens adds GLP-1 coverage navigation, Medicare Bridge support and pharmacist outreach to its virtual weight management ...
GEODIS' David Frouin explains why securing the lane outranks sustainability and why full corridor models are the cold chain trend to watch. Efficiency and security matters more than just ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results